[Hub]/) : Traits : Impedance of whole body : ← →

chr11:61,664,757-63,284,510

Best TWAS P=1.16e-10 · Best GWAS P=1.16e-10 conditioned to 1

Associated models

#	Study	Tissue	Gene	h2	eQTL R2	model	# weights	model R2	model R2 P	eQTL GWAS Z	TWAS Z	TWAS P	Top SNP corr	PP3	PP4	joint
12	GTEx	Skin Not Sun Exposed Suprapubic	ROM1	0.15	0.08	lasso	1	0.06	2.8e-04	-6.4	6.4	1.2e-10	-1.00	0.00	0.97	TRUE
24	YFS	Blood	INTS5	0.09	0.12	lasso	4	0.12	1.9e-38	-6.4	-6.4	1.4e-10	0.97	0.01	0.99	FALSE
44	The Cancer Genome Atlas	Thyroid Carcinoma	EML3	0.11	0.10	blup	28	0.12	2.3e-11	-5.4	-6.4	1.4e-10	0.78	0.03	0.97	FALSE
20	GTEx	Thyroid	B3GAT3	0.18	0.09	lasso	5	0.12	1.4e-09	-6.4	-6.4	1.8e-10	0.90	0.00	1.00	FALSE
33	The Cancer Genome Atlas	Brain Lower Grade Glioma	C11orf83	0.02	0.01	blup	24	0.01	1.5e-02	-6.0	6.3	2.6e-10	-0.86	0.01	0.84	FALSE
9	GTEx	Nerve Tibial	B3GAT3	0.18	0.11	lasso	3	0.09	4.7e-07	-6.4	-6.3	3.5e-10	0.97	0.00	1.00	FALSE
14	GTEx	Skin Not Sun Exposed Suprapubic	B3GAT3	0.18	0.11	lasso	3	0.11	9.8e-07	-6.4	-6.3	4.0e-10	0.96	0.00	1.00	FALSE
40	The Cancer Genome Atlas	Prostate Adenocarcinoma	C11orf83	0.03	0.03	blup	24	0.02	5.5e-03	-6.4	6.1	1.0e-09	-0.94	0.00	0.99	FALSE
26	The Cancer Genome Atlas	Breast Invasive Carcinoma	C11orf83	0.01	0.00	blup	23	0.01	4.2e-03	-5.9	6.0	2.2e-09	-0.86	0.01	0.62	FALSE
32	The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	EML3	0.06	0.09	lasso	2	0.08	1.6e-05	-5.9	-5.9	2.7e-09	0.79	0.02	0.97	FALSE
2	GTEx	Adipose Visceral Omentum	ROM1	0.29	0.16	lasso	8	0.23	3.7e-12	-5.0	5.9	4.5e-09	-0.81	0.22	0.78	FALSE
39	The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	EML3	0.03	0.02	blup	27	0.03	3.5e-03	-5.4	-5.8	5.1e-09	0.81	0.02	0.73	FALSE
10	GTEx	Ovary	ROM1	0.25	0.00	lasso	5	0.00	3.3e-01	-5.4	5.8	5.2e-09	-0.81	0.07	0.27	FALSE
35	The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	EEF1G	0.06	0.03	blup	27	0.04	4.5e-03	-5.9	5.7	1.2e-08	-0.78	0.01	0.80	FALSE
15	GTEx	Skin Sun Exposed Lower leg	EML3	0.32	0.25	enet	19	0.26	8.0e-22	-4.9	-5.7	1.5e-08	0.71	0.92	0.08	FALSE
37	The Cancer Genome Atlas	Lung Adenocarcinoma	EML3	0.03	0.03	blup	28	0.03	8.4e-05	-5.0	-5.7	1.5e-08	0.76	0.31	0.67	FALSE
28	The Cancer Genome Atlas	Breast Invasive Carcinoma	ROM1	0.01	0.02	enet	4	0.02	2.4e-04	-5.4	5.7	1.6e-08	-0.74	0.11	0.71	FALSE
7	GTEx	Lung	ROM1	0.25	0.18	enet	13	0.20	2.2e-15	-5.0	5.6	1.9e-08	-0.78	0.87	0.13	FALSE
13	GTEx	Skin Not Sun Exposed Suprapubic	EML3	0.20	0.19	lasso	3	0.24	2.7e-13	-4.9	-5.6	1.9e-08	0.78	0.15	0.85	FALSE
22	METSIM	Adipose	B3GAT3	0.08	0.06	enet	16	0.07	5.4e-11	-5.9	-5.6	2.1e-08	0.82	0.02	0.98	FALSE
8	GTEx	Nerve Tibial	EML3	0.17	0.10	lasso	4	0.09	3.9e-07	-4.9	-5.6	2.2e-08	0.77	0.14	0.86	FALSE
1	GTEx	Adipose Subcutaneous	ROM1	0.25	0.17	lasso	3	0.18	1.5e-14	-5.4	5.6	2.3e-08	-0.78	0.64	0.36	FALSE
23	YFS	Blood	EML3	0.20	0.31	lasso	12	0.33	1.3e-110	-5.4	-5.5	3.4e-08	0.76	0.76	0.24	FALSE
4	GTEx	Cells Transformed fibroblasts	EML3	0.19	0.16	lasso	9	0.18	7.3e-14	-5.4	-5.5	4.0e-08	0.81	0.73	0.27	FALSE
18	GTEx	Testis	EML3	0.27	0.22	enet	15	0.29	2.7e-13	-5.0	-5.5	4.0e-08	0.82	0.37	0.63	FALSE
5	GTEx	Cells Transformed fibroblasts	HNRNPUL2	0.11	0.04	enet	14	0.05	9.8e-05	-3.7	5.5	4.2e-08	-0.84	0.03	0.96	FALSE
31	The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	EEF1G	0.07	0.04	blup	28	0.07	9.8e-05	-5.4	5.5	4.9e-08	-0.74	0.05	0.78	FALSE
38	The Cancer Genome Atlas	Lung Adenocarcinoma	ROM1	0.04	0.04	blup	23	0.04	9.5e-06	-5.0	5.4	5.2e-08	-0.80	0.26	0.74	FALSE
25	The Cancer Genome Atlas	Bladder Urothelial Carcinoma	EEF1G	0.04	0.05	lasso	1	0.04	1.1e-04	-5.4	5.4	5.7e-08	-0.73	0.06	0.86	FALSE
41	The Cancer Genome Atlas	Prostate Adenocarcinoma	EML3	0.09	0.14	lasso	1	0.14	3.4e-14	-5.4	-5.4	5.7e-08	0.73	0.32	0.68	FALSE
11	GTEx	Pituitary	STX5	0.22	0.11	lasso	3	0.11	9.7e-04	-2.4	5.4	6.2e-08	-0.55	0.05	0.44	FALSE
45	The Cancer Genome Atlas	Thyroid Carcinoma	ROM1	0.03	0.02	blup	23	0.02	1.1e-02	-5.0	5.4	6.4e-08	-0.77	0.05	0.61	FALSE
3	GTEx	Cells Transformed fibroblasts	MTA2	0.06	0.09	lasso	1	0.07	3.0e-06	-5.4	-5.4	7.2e-08	0.82	0.47	0.46	FALSE
27	The Cancer Genome Atlas	Breast Invasive Carcinoma	EML3	0.02	0.02	lasso	4	0.02	2.5e-05	-5.4	-5.4	8.1e-08	0.73	0.34	0.64	FALSE
42	The Cancer Genome Atlas	Soft Tissue Sarcoma	ROM1	0.06	0.05	blup	24	0.03	8.1e-03	-5.0	5.4	8.3e-08	-0.73	0.06	0.24	FALSE
16	GTEx	Spleen	MTA2	0.26	0.07	enet	19	0.07	8.7e-03	-5.0	-5.3	9.6e-08	0.68	0.05	0.75	FALSE
29	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	EML3	0.06	0.05	blup	27	0.06	7.6e-07	-6.0	-5.3	1.1e-07	0.77	0.03	0.97	FALSE
36	The Cancer Genome Atlas	Lung Adenocarcinoma	EEF1G	0.06	0.08	lasso	8	0.08	5.9e-10	-5.0	5.3	1.1e-07	-0.78	0.10	0.90	FALSE
43	The Cancer Genome Atlas	Testicular Germ Cell Tumors	TTC9C	0.25	0.03	enet	13	0.04	1.8e-02	3.2	-5.2	1.5e-07	0.43	0.00	0.01	FALSE
30	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	EEF1G	0.11	0.12	blup	27	0.13	5.5e-14	-5.0	5.2	1.8e-07	-0.73	0.18	0.82	FALSE
17	GTEx	Stomach	EML3	0.11	0.04	enet	5	0.03	2.1e-02	-5.3	-5.2	1.9e-07	0.79	0.09	0.43	FALSE
6	GTEx	Esophagus Mucosa	EML3	0.40	0.43	lasso	8	0.46	1.8e-33	-5.0	-5.2	2.3e-07	0.72	0.92	0.08	FALSE
19	GTEx	Thyroid	ROM1	0.17	0.16	lasso	8	0.16	3.6e-12	-4.9	5.2	2.3e-07	-0.72	0.81	0.19	FALSE
34	The Cancer Genome Atlas	Brain Lower Grade Glioma	EML3	0.03	0.04	blup	28	0.03	7.6e-05	-5.4	-5.2	2.3e-07	0.74	0.22	0.74	FALSE
21	GTEx	Whole Blood	EML3	0.17	0.09	lasso	7	0.08	6.3e-08	-5.0	-5.1	2.8e-07	0.74	0.76	0.24	FALSE